IMATINIB , PONATINIB , BOSUTINIB, NILOTINIB, DASATINIB
Approved small_molecule active
Quick answer
IMATINIB , PONATINIB , BOSUTINIB, NILOTINIB, DASATINIB for Chronic myeloid leukaemia is a Approved program (small_molecule) at Disc Medicine with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Disc Medicine
- Indication
- Chronic myeloid leukaemia
- Phase
- Approved
- Modality
- small_molecule
- Status
- active